November 28, 2024

Oracle, Dell Dip in Thursday’s Market Cap Stock Movers

Thursday’s trading session is witnessing notable fluctuations among stocks across the board, with significant movements in both the mega-cap and large-cap categories. Oracle Corp (NYSE:ORCL) and Dell Inc (NYSE:DELL) are among the stocks experiencing declines, while MicroStrategy Inc (NASDAQ:MSTR) is surging. Here’s a look at some of the key stock movers today, spanning from mega-caps to small caps.

Mega-Cap Movers (Market Cap $200B+):

  • Oracle Corp (ORCL): -4.03%
  • Salesforce Com (NYSE:CRM): -3.84%
  • Avago Technologies (NASDAQ:AVGO): -3.08%
  • Servicenow Inc (NYSE:NOW): -2.68%
  • Adobe Sys Inc (NASDAQ:ADBE): -2.21%

Large-Cap Stock Movers (Market Cap $10B-$200B):

  • Dell Inc (DELL): -12.25%
  • Hewlett-pack (NYSE:HPQ): HP stock downgraded to Hold by HSBC on weak 1QFY25 outlook and rising commodity costs; -11.36%
  • MicroStrategy Inc (MSTR): +9.94%
  • Autodesk Inc (NASDAQ:ADSK): -8.59%
  • Nutanix Inc (NASDAQ:NTNX): Nutanix to Present at Upcoming Investor Conference; -7.81%
  • BeiGene (NASDAQ:BGNE): +7.31%
  • Reinvent Technology Partners Y (AUR): +7.27%
  • Li Auto Inc (NASDAQ:LI): American Lithium Reports Results of Annual General and Special Meeting; +6.78%
  • IBIT NASDAQ (IBIT): +6.44%
  • FBTC NYSE (FBTC): +6.37%

Mid-Cap Stock Movers (Market Cap $2B-$10B):

  • SVF Investment 3 (SYM): -35.87%
  • Iris Energy (IREN): +29.71%
  • Arrowhead Research Corp (NASDAQ:ARWR): +24.23%
  • Urban outfitters (NASDAQ:URBN): +18.31%
  • Hut 8 Mining PK (HUT): +16.5%
  • HCM Acquisition (MRNO): +16.17%
  • Good Works Acquisition (CIFR): +14.56%
  • MSTU (MSTU): +13.93%

Small-Cap Stock Movers (Market Cap $300M-$2B):

  • Advanced Photonix Inc (API): +33.97%
  • ETHU (ETHU): +18.79%
  • Golden Bull (BTBT): +18.45%
  • Fate Therap (NASDAQ:FATE): +18.28%
  • Kingsoft Cloud Holdings Ltd (KC): +17.42%
  • Immunome Inc (NASDAQ:IMNM): +16.83%
  • Wowo Ltd (MFH): -16.32%
  • Semler Scientifc (NASDAQ:SMLR): +16.06%
  • Applied Therapeutics Inc (NASDAQ:APLT): FDA declines approval for Applied Therapeutics’ Galactosemia drug; -16.06%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com